LB Pharmaceuticals Files Prospectus For Offering Mixed Shelf; Terms Undisclosed

Benzinga Newsdesk www.benzinga.com Neutral 93.2%

Neg 0% Neu 93.2% Pos 0%

https://www.sec.gov/Archives/edgar/data/1691082/000119312526410651/d171801ds3asr.htm

Comments

No comments yet. Be the first!